Description of neurodevelopmental phenotypes associated with 10 genetic neurodevelopmental disorders: A scoping review
- PMID: 33179249
- DOI: 10.1111/cge.13882
Description of neurodevelopmental phenotypes associated with 10 genetic neurodevelopmental disorders: A scoping review
Abstract
Neurodevelopmental disorders (NDDs) are a heterogeneous group of conditions including intellectual disability, global developmental delay, autism spectrum disorder, and attention deficit hyperactivity disorder. Advances in genetic diagnostic technology have led to the identification of a number of NDD-associated genes, but reports of cognitive and developmental outcomes in affected individuals have been variable. The objective of this scoping review is to synthesize available information pertaining to the developmental outcomes of individuals with pathogenic variants in ten emerging recurrent NDD-associated genes identified from large scale sequencing studies; ADNP, ANKRD11, ARID1B, CHD2, CHD8, CTNNB1, DDX3X, DYRK1A, SCN2A, and SYNGAP1. After a comprehensive search, 260 articles were selected that reported on neurodevelopmental measures or diagnoses. We identify the spectrum of developmental outcomes for each genetic NDD, including prevalence of intellectual disability, frequency of co-morbid NDDs such as ADHD and autism, and commonly reported medical issues that can help inform diagnosis and treatment. There are significant gaps in our understanding of the natural history of these conditions. Future research focusing on barriers to assessment, the development of modified assessment tools appropriate for long-term outcomes in genetic NDD, and collection of longitudinal data will increase understanding of prognosis in these conditions and inform evaluations of treatment.
Keywords: autism spectrum disorder; developmental delay; intellectual disability; neurodevelopmental disorders.
© 2020 John Wiley & Sons A/S . Published by John Wiley & Sons Ltd.
Similar articles
-
Expanding the clinical phenotype and genetic spectrum of PURA-related neurodevelopmental disorders.Brain Dev. 2021 Oct;43(9):912-918. doi: 10.1016/j.braindev.2021.05.009. Epub 2021 Jun 8. Brain Dev. 2021. PMID: 34116881
-
Species-conserved SYNGAP1 phenotypes associated with neurodevelopmental disorders.Mol Cell Neurosci. 2018 Sep;91:140-150. doi: 10.1016/j.mcn.2018.03.008. Epub 2018 Mar 24. Mol Cell Neurosci. 2018. PMID: 29580901 Free PMC article. Review.
-
Commonalities and distinctions between two neurodevelopmental disorder subtypes associated with SCN2A and SCN8A variants and literature review.Mol Genet Genomic Med. 2022 May;10(5):e1911. doi: 10.1002/mgg3.1911. Epub 2022 Mar 29. Mol Genet Genomic Med. 2022. PMID: 35348308 Free PMC article. Review.
-
Meta-analysis and multidisciplinary consensus statement: exome sequencing is a first-tier clinical diagnostic test for individuals with neurodevelopmental disorders.Genet Med. 2019 Nov;21(11):2413-2421. doi: 10.1038/s41436-019-0554-6. Epub 2019 Jun 11. Genet Med. 2019. PMID: 31182824 Free PMC article.
-
Phenotypic and genetic analysis of children with unexplained neurodevelopmental delay and neurodevelopmental comorbidities in a Chinese cohort using trio-based whole-exome sequencing.Orphanet J Rare Dis. 2024 May 19;19(1):205. doi: 10.1186/s13023-024-03214-w. Orphanet J Rare Dis. 2024. PMID: 38764027 Free PMC article.
Cited by
-
Consensus reporting guidelines to address gaps in descriptions of ultra-rare genetic conditions.NPJ Genom Med. 2024 Apr 6;9(1):27. doi: 10.1038/s41525-024-00408-w. NPJ Genom Med. 2024. PMID: 38582909 Free PMC article.
-
Clinical phenotypic spectrum of CTNNB1 neurodevelopmental disorder.Clin Genet. 2024 May;105(5):523-532. doi: 10.1111/cge.14487. Epub 2024 Jan 21. Clin Genet. 2024. PMID: 38247296 Free PMC article.
-
Clinical and Neurobiological Aspects of TAO Kinase Family in Neurodevelopmental Disorders.Front Mol Neurosci. 2021 Mar 24;14:655037. doi: 10.3389/fnmol.2021.655037. eCollection 2021. Front Mol Neurosci. 2021. PMID: 33867937 Free PMC article.
-
Impaired macroglial development and axonal conductivity contributes to the neuropathology of DYRK1A-related intellectual disability syndrome.Sci Rep. 2022 Nov 19;12(1):19912. doi: 10.1038/s41598-022-24284-5. Sci Rep. 2022. PMID: 36402907 Free PMC article.
-
Clinical Study of 8 Cases of CHD2 Gene Mutation-Related Neurological Diseases and Their Mechanisms.Front Cell Dev Biol. 2022 Mar 21;10:853127. doi: 10.3389/fcell.2022.853127. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 35386198 Free PMC article.
References
REFERENCES
-
- Association. AP. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Arlington, VA, USA: American Psychiatric Association Publishing; 2013.
-
- Wilfert AB, Sulovari A, Turner TN, Coe BP, Eichler EE. Recurrent de novo mutations in neurodevelopmental disorders: properties and clinical implications. Genome Med. 2017;9(1):101.
-
- Vickers RR, Gibson JS. A review of the genomic analysis of children presenting with developmental delay/intellectual disability and associated dysmorphic features. Cureus. 2019;11(1):e3873.
-
- Carvill GL, Mefford HC. Next-generation sequencing in intellectual disability. J Pediatr Genet. 2015;4(3):128-135.
-
- Iossifov I, O'Roak BJ, Sanders SJ, et al. The contribution of de novo coding mutations to autism spectrum disorder. Nature. 2014;515(7526):216-221.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous